EFX.NYSEEquifax INC

Form 4: Equifax EVP, Chief Legal Officer John J Kelley III Reports Stock and Option Awards

Sentiment:

SEC Form 4


John J Kelley III, EVP and Chief Legal Officer of Equifax Inc., reports the acquisition of stock and option awards as part of the company's long-term incentive plan.

Summary

  • On February 10, 2025, John J Kelley III, EVP and Chief Legal Officer of Equifax Inc., reported transactions related to Equifax stock.
  • Kelley acquired 3,213 shares of common stock at $0.00 as an annual equity grant under the company's long-term incentive plan, which vests 100% on February 10, 2028.
  • He also acquired options to buy 10,322 shares of common stock at an exercise price of $252.90, vesting in three equal annual increments starting February 10, 2026.
  • Following these transactions, Kelley beneficially owns 14,492 shares of common stock and options for 10,322 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and aligns executive interests with company performance.

Positives

  • The equity grants align executive compensation with the long-term performance of Equifax.
  • The vesting schedules encourage continued service and commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the equity grants.

Industry Context

Equity grants are a common practice in executive compensation packages within the financial services and technology industries, aligning executive interests with shareholder value and company performance.

Comparison to Industry Standards

  • Equity compensation practices vary across the industry, but grants of restricted stock and stock options are common.
  • Companies like Experian and TransUnion, which are direct competitors of Equifax, also utilize similar long-term incentive plans for their executives.
  • The vesting schedules and grant sizes are generally benchmarked against peer companies to ensure competitiveness and retention.

Stakeholder Impact

  • The equity grants aim to align the executive's interests with those of the shareholders, potentially driving long-term value creation.
  • Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
02/10/2025Date of the equity grant and transaction.
02/10/2026First vesting date for the stock options (one-third).
02/10/2028Vesting date for the restricted stock units (100%).
02/10/2035Expiration date for the stock options.
02/12/2025Date of the form filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.